824487

CorneaGen - Boston — FEI 1000513310

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 28, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Waltham, MA (United States)

Citations

IDCFRDescription
1236321 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
1239821 CFR 1271.230(a)Validation & approval--established procedures
1240521 CFR 1271.250(a)Controlling the labeling of HCT/Ps